Venture Partner play a crucial role in any startup. It takes an extraordinary person to fulfil the Venture Partner role. We have selected these Venture Partner’s for this list as they are inspiring for a variety of reasons – whether that’s pushing boundaries, creating groundbreaking products, or doing their bit to save the world.
Our analysts did their best to select be best, and most innovative Venture Partner’s. The list is in no particular order!
Pamir Gelenbe
Venture Partner @ Hummingbird Ventures
FollowPamir Gelenbe on Facebook, Twitter or Linkedin.
[custom-twitter-feeds screenname=”gelenbe”]
Spoiler title
Pamir is a Managing Partner at Libertus Capital and invests on decentralised systems, entreprise blockchain, and digital assets. He is an investor in Kraken, Ledger, Crypto Facilities and Shapeshift. Previously, he served as a Partner at Hummingbird Ventures, and also worked at Morgan Stanley and D.E. Shaw. Pamir graduated from Duke University and Columbia University with a BSc. in Electrical Engineering and MSc. in Operations Research.
Learn more about Pamir Gelenbe on Crunchbase… Read more aboutHummingbird Ventures on Crunchbase…
Nadav Rosenberg
Venture Partner @ Entrepreneur First
FollowNadav Rosenberg on Facebook, Twitter or Linkedin.
[custom-twitter-feeds screenname=”nadavrosenberg”]
Spoiler title
Nadav leads Taboola’s expansion and operations in Europe and Australia. Prior to joining Taboola, Nadav was a member of the founding team of Groupon UK & IR, taking part in building and managing Groupon’s business in the UK. Before joining Groupon, Nadav worked as a strategy consultant with McKinsey & Company in London. Nadav is based in London and holds an MBA from INSEAD, France.
Learn more about Nadav Rosenberg on Crunchbase… Read more aboutEntrepreneur First on Crunchbase…
Chris Mairs
Venture Partner @ Entrepreneur First
FollowChris Mairs on Facebook, Twitter or Linkedin.
[custom-twitter-feeds screenname=”Chris_mairs”]
Spoiler title
Chris joined Metaswitch as one of the founding team in 1981. Prior to this, he acquired a degree in Computing from Cambridge University and worked for IBM on mainframe and communications systems software. In the early years, Chris was lead architect for all the company’s communications products. Next, he was responsible for the creation and development of our successful real time conferencing business. In 1995 this led to a strategic relationship to provide Microsoft with core technology for NetMeeting (Microsoft’s entry into the data conferencing space). Chris also oversaw the company’s product strategy for messaging and conferencing solutions, targeted at a broad spectrum of service providers, and later served as Chief Technical Officer with responsibility for product management and long-term technology strategy.
Learn more about Chris Mairs on Crunchbase… Read more aboutEntrepreneur First on Crunchbase…
Hermann Hauser
Co-founder, Director, and Venture Partner @ Amadeus Capital Partners
FollowHermann Hauser on Facebook, Twitter or Linkedin.
[custom-twitter-feeds screenname=”hermannhauser”]
Spoiler title
Hermann Hauser co-founded Amadeus Capital Partners in 1997 with Anne Glover and Peter Wynn. In his long and successful history as an entrepreneur and venture capitalist, Hermann has founded or co-founded companies in a wide range of technology sectors. These include Acorn Computers (where he helped spin out ARM), Active Book Company, Virata, Net Products, NetChannel and Cambridge Network Limited. He was a founder director of IQ (Bio), IXI Limited, Vocalis, SynGenix, Advanced Displays Limited (acquired by Cambridge Display Technology), Electronic Share Information Limited, E*Trade UK and has supported many other start-ups. Hermann’s successes at Amadeus include: CSR plc (LON: CSR); Entropic Research Laboratory (acquired by Microsoft in 1999); Solexa (acquired by Illumina in 2007); and Icera (acquired by Nvidia in 2011). He is currently a non-executive director of XMOS, a company that is revolutionising re-configurable silicon chips; Intune Networks, a pioneer in the field of Optical Packet Switch & Transport; Tobii, the world leader in eye tracking and gaze detection; Plastic Logic, the first company to commercialize flexible plastic transistors (currently used in computer displays); and Cambridge Broadband Networks, a leader in point-to-multipoint wireless backhaul products. Hermann holds an MA in Physics from Vienna University and a PhD in Physics from the University of Cambridge. He is a Fellow of the Institute of Physics and of the Royal Academy of Engineering, and an Honorary Fellow of King’s College, Cambridge. Hermann holds honorary doctorates from the Universities of Bath, Loughborough and from Anglia Ruskin University and was awarded an Honorary CBE for ‘innovative service to the UK enterprise sector’ in 2001. In 2004, he was made a member of the Government’s Council for Science & Technology. In 2012 he became a Fellow of the Royal Society in recognition of his contribution to the translation of science into business, and in 2013 a Distinguished Fellow of BCS, the Chartered Institute for IT. Austrian by birth, Hermann speaks German, English and conversational Italian and French.
Learn more about Hermann Hauser on Crunchbase… Read more aboutAmadeus Capital Partners on Crunchbase…
David Buttress
Venture Partner @ 83North
FollowDavid Buttress on Facebook, Twitter or Linkedin.
[custom-twitter-feeds screenname=”davidjusteat”]
Spoiler title
David is based in our London office. He joined JUST EAT in March 2006 to launch its UK business, and was appointed CEO in January 2013. David led JUST EAT in the UK from startup to becoming Europe’s largest technology IPO in a decade. As CEO of JUST EAT David was responsible for leading several major investments and acquisitions. Highlights include acquiring leading technology businesses in Australia (menulog), Spain (la nevera roja) , Italy (Pizza Bo), Canada (Skip the Dishes), UK (hungryhouse and Flypay) and LATAM (ifood). In 2014, David was named Entrepreneur of the Year at the Investor Allstars Awards and he was also named as one of Britain’s most influential people in the Debrett’s 500 2015, 2016 and 2017. David was a Special Advisor to 83North for several years before joining as a partner in 2017.
Learn more about David Buttress on Crunchbase… Read more about83North on Crunchbase…
Alexandre Noschese
Co-Founder & Venture Partner @ ONEVC
FollowAlexandre Noschese on Facebook, Twitter or Linkedin.
Read more aboutONEVC on Crunchbase…
Katherine Ireland
Venture Partner @ Sprints Capital
FollowKatherine Ireland on Facebook, Twitter or Linkedin.
Spoiler title
Katherine Ireland joined Palamon having earned her MBA from Harvard Business School in 2015. She was previously an Associate in the London-based investment team at Centerbridge Partners with responsibility for managing distressed credit and private equity investments with a focus on European corporate situations. Ms Ireland began her career at Goldman Sachs International as an Analyst where she advised European industrial companies on strategic alternatives and financing. In addition to her graduate degree, Ms Ireland earned a BA in Economics and History magna cum laude, Phi Beta Kappa, from Williams College, Massachusetts. She now serves on the board of the Center for Development Economics based in Williamstown
Learn more about Katherine Ireland on Crunchbase… Read more aboutSprints Capital on Crunchbase…
Vishal Gulati
Venture Partner @ Molten Ventures
FollowVishal Gulati on Facebook, Twitter or Linkedin.
[custom-twitter-feeds screenname=”vgul”]
Spoiler title
Vishal Gulati: Vishal serves as a venture partner specialising in digital health at DFJ Esprit, Europe’s leading Silicon Valley style venture capital firm with over $1b under management. Since 2012, Vishal has been Europe’s leading promoter of investment into the emerging digital health sector and chairman of Digital Health Forum, which supports the best in class digital health companies to grow into global enterprises. Vishal serves on several boards including Horizon Discovery Group PLC (Cambridge, UK), a gene editing company; Fluidics Analytics (Cambridge, UK), a next gen protein discovery engine, Frameshift a healthcare information flow platform (London, UK) and EcoEos (San Francisco, USA), a consumer genomics business. His previous investments include Napo Pharmaceuticals, Glenmark, Renovo and Phagenesis.
Learn more about Vishal Gulati on Crunchbase…Molten Ventures is Europe’s largest listed tech VC firm. We inject the most visionary companies with energy to help them transform and grow. Read more aboutMolten Ventures on Crunchbase…
Kasia Robinski
Venture Partner @ Beacon Capital
FollowKasia Robinski on Facebook, Twitter or Linkedin.
Read more aboutBeacon Capital on Crunchbase…
Simon Cartmell
Venture Partner @ IP Group Plc
FollowSimon Cartmell on Facebook, Twitter or Linkedin.
Spoiler title
With 35 years pharmaceutical, biotech and medtech experience gained in commercial, product development, supply chain, strategic leadership and corporate executive roles, Simon is a serial entrepreneur in early stage healthcare businesses. As CEO of ApaTech Ltd, a QMUL spinout, he developed a world leader in orthobiologics prior to its sale to Baxter for $330m in March 2010. Prior to joining ApaTech in 2004, Simon was a Main Board Director of Celltech Group plc, serving as CEO, Celltech Pharmaceuticals, prior to which he served as COO of Vanguard Medica (later Vernalis plc). The early part of his career was spent at Glaxo/Glaxo Wellcome plc in a series of senior UK and international commercial, supply chain and strategic development leadership roles. In 2016 Simon was awarded the OBE for services to the healthcare business sector.
Learn more about Simon Cartmell on Crunchbase…IP Group is an IP commercialization company specializing in evolving great ideas into world-changing businesses. Read more aboutIP Group Plc on Crunchbase…
Kevin D’Silva
Venture Partner @ Catapult Ventures
FollowKevin D’Silva on Facebook, Twitter or Linkedin.
Spoiler title
Kevin is a Venture Partner with Catapult’s GM&C Life Sciences Fund, where he assesses investment opportunities and works with the Fund’s smaller investments to help companies successfully grow, with a particular focus on medical devices. Kevin has held a number of non-executive and Chairman positions, including Monica Healthcare, which generated a 3.5x cash return for Catapult, and Crystallon, which generated a 5.2x cash return. He is also a Director and former Chairman of both Surface Transforms plc (AIM listed) and Hallmarq Veterinary Imaging Ltd. Kevin was a founding director of Ferraris Group plc (FTSE: listed) and created Salusinvest in 2006 to invest in a number of EU and US life science businesses. He is also a former Director of Acuity VCT 3 and Octopus VCT 1. Kevin graduated from Leeds University with a BSc in Chemical Engineering and has an MBA from Manchester Business School.
Learn more about Kevin D’Silva on Crunchbase…Catapult Ventures specialises in providing Equity Capital for businesses requiring between £50k and £2m. Read more aboutCatapult Ventures on Crunchbase…
Spencer Hyman
Venture Partner @ Wellington Partners
FollowSpencer Hyman on Facebook, Twitter or Linkedin.
[custom-twitter-feeds screenname=”sdhyman”]
Read more aboutWellington Partners on Crunchbase…
Paul McNabb
Venture Partner @ Episode 1
FollowPaul McNabb on Facebook, Twitter or Linkedin.
Spoiler title
Paul has had a highly successful career in high tech as both a senior executive and an entrepreneur. Most recently, he served as the Chief Strategy Officer for Cisco Services, a $12bn division of Cisco, where he led the global strategy and acquisitions team. Previously he had run a series of global businesses for Cisco. As an entrepreneur he founded and exited two businesses in the US, one an innovative consulting firm sold to Cambridge Technology Partners, and the second a B2B Social Network for CIOs sold to Earthweb. His early background was in consulting, working for Accenture and other major international consulting firms, including his own. He has worked in venture capital in the US, and has broad experience in many B2B technologies. He has also worked globally, living in Shanghai, New York, San Francisco and multiple European Countries. With a passion for strategy and marketing, and an extensive network of contacts and experience to draw on, Paul enjoys nothing better than working with entrepreneurs to tease out the goals and priorities they need to operationalize their vision.
Learn more about Paul McNabb on Crunchbase… Read more aboutEpisode 1 on Crunchbase…
Jamie Urquhart
Venture Partner @ Pond Ventures
FollowJamie Urquhart on Facebook, Twitter or Linkedin.
Spoiler title
Based in Europe, Jamie Urquhart is a Venture Partner with Pond. Jamie is highly experienced in global technology licensing businesses. Currently a board member at picoChip, Jamie was with ARM Holdings plc, from its inception in November 1990 until November 2002. During that time he undertook a number of roles, including Chief Operating Officer and Director, and latterly Chief Strategy Officer. Before that he was with Acorn Computers Limited, joining in 1984 as a VLSI Design Engineer, becoming VLSI Design Manager of the VLSI Design Group. Jamie is also a non-executive director of Imperas, nCipher, Antenova, and SplashPower.
Learn more about Jamie Urquhart on Crunchbase… Read more aboutPond Ventures on Crunchbase…
Tom Buehlmann
Venture Partner @ DN Capital
FollowTom Buehlmann on Facebook, Twitter or Linkedin.
Spoiler title
Tom has over 15 years of experience with technology-enabled marketing service businesses, with a particular focus on general management, sales and marketing. Until recently, Tom served as Executive Chairman of Lumata Group, a global digital customer engagement, analytics and loyalty company. Previously, he spent a number of years as CEO and in senior management at EYC, a loyalty CRM and analytics provider, and at Catalina Marketing, a provider of targeted point-of-sale couponing. Tom was also a Venture Partner at DN Capital, where he managed and evaluated existing and new investments in the e-commerce, data and retail technology sectors. Early in his career, Tom had a number of sales and marketing roles at Procter & Gamble and Lindt & Sprüngli. He holds an MA from Cambridge University.
Learn more about Tom Buehlmann on Crunchbase… Read more aboutDN Capital on Crunchbase…
Candice Lo
Venture Partner @ Moonfire Ventures
FollowCandice Lo on Facebook, Twitter or Linkedin.
[custom-twitter-feeds screenname=”candice_lo”]
Spoiler title
Candice Lo is a Partner at Blossom Capital. Candice Lo was an Expansion Manager at Uber, Inc. She oversaw Uber’s expansion efforts in China. She worked at Uber for five years.
Learn more about Candice Lo on Crunchbase… Read more aboutMoonfire Ventures on Crunchbase…
Martin Gibson
Venture Partner @ Accel
FollowMartin Gibson on Facebook, Twitter or Linkedin.
[custom-twitter-feeds screenname=”martincgibson”]
Read more aboutAccel on Crunchbase…
Steve Mountain
Venture Partner @ Beacon Capital
FollowSteve Mountain on Facebook, Twitter or Linkedin.
Read more aboutBeacon Capital on Crunchbase…
Pratima Aiyagari
Venture Partner @ Nauta Capital
FollowPratima Aiyagari on Facebook, Twitter or Linkedin.
[custom-twitter-feeds screenname=”paiyagari”]
Spoiler title
Pratima is a Venture Partner at Nauta Capital and is based in London. At Nauta, Pratima focuses on enterprise software and deep tech domains. Pratima has 18+ years of professional experience. She is a software developer by background and spent several years in Silicon Valley working on developing intelligent network services in the network management domain. Pratima joins Nauta from US-based cybersecurity-focused investment firm Paladin Capital. Previously, Pratima led investments and acquisitions at Cisco Corporate Development in Europe with a specific focus on ML/AI, Enterprise Collaboration and Silicon. During her investment career, Pratima led an investment or held board seats in Aimotive, Adbrain, Evrythng, Secure Code Warrior, decentriq, Dashbird, and several fund investments. She also managed investments in several companies including Behaviosec, Italtel, ip.access, and Corvil. Pratima received her MBA from INSEAD in France and an MS in computer science from the Virginia Polytechnic Institute and State University in the US. Pratima is a co-author of a US patent in the area of network device clusters and high availability.
Learn more about Pratima Aiyagari on Crunchbase…Nauta Capital is a pan-European Venture Capital firm investing in early stage technology companies. Read more aboutNauta Capital on Crunchbase…
George Whitehead
Venture Partner Manager @ Octopus Ventures
FollowGeorge Whitehead on Facebook, Twitter or Linkedin.
[custom-twitter-feeds screenname=”georgewhitehead”]
Read more aboutOctopus Ventures on Crunchbase…
Alexandre Gonthier
Venture Partner @ Wellington Partners
FollowAlexandre Gonthier on Facebook, Twitter or Linkedin.
[custom-twitter-feeds screenname=”alexgonthier”]
Read more aboutWellington Partners on Crunchbase…
Alan Barge
Venture Partner @ Delin Ventures
FollowAlan Barge on Facebook, Twitter or Linkedin.
Read more aboutDelin Ventures on Crunchbase…
Guclu Ozenci
Venture Partner @ Founder Institute
FollowGuclu Ozenci on Facebook, Twitter or Linkedin.
[custom-twitter-feeds screenname=”GucluOzenci”]
Read more aboutFounder Institute on Crunchbase…
Howard Bell
Venture Partner @ Octopus Ventures
FollowHoward Bell on Facebook, Twitter or Linkedin.
[custom-twitter-feeds screenname=”hbell1999″]
Spoiler title
Howard is presently leading growth at FutureLearn – a new education technology venture owned by the Open University. Howard was a founder member of PayPal Europe, and led an acceleration of UK and international growth at JustGiving , an online social fundraising platform for charities .Previously headed up business development , product strategy and partnerships at Content Technologies (now ClearSwift) , Barclaycard Payments and Dow Jones.
Learn more about Howard Bell on Crunchbase… Read more aboutOctopus Ventures on Crunchbase…
Rajesh Chopra
Venture Partner @ Apple Tree Partners
FollowRajesh Chopra on Facebook, Twitter or Linkedin.
Spoiler title
Raj Chopra is a venture partner at ATP. At The Institute of Cancer Research in London, as director of the Cancer Research UK Cancer Therapeutics Unit, he led one of the largest academic drug discovery groups in the world and focused on targeted protein degradation and complex 3D cell culture models. Raj also worked at Celgene from 2009 to 2016 as corporate vice president of Translational and Early Drug Development, leading an international team of more than 100 scientists. Before joining Celgene, he held leadership positions in AstraZeneca’s Oncology Therapeutics group in the UK and US. Raj started his academic career as the director of Hematological Oncology at Christie Hospital and was group leader at the Paterson Institute of Cancer Research, both located in Manchester, UK. He is a non-executive director of Artios Pharma, established to develop a next-generation DNA damage response target pipeline of cancer therapeutics, and co-founder of Monté Rosa Therapeutics, a biotech focused on targeted protein degradation. Raj trained in medicine at University College London, where he earned his PhD in medicine, cell and molecular biology. He is a fellow of the Royal College of Physicians of London, the Royal College of Pathologists, and the Royal Society of Biology.
Learn more about Rajesh Chopra on Crunchbase… Read more aboutApple Tree Partners on Crunchbase…
Pierre Suhrcke
Venture Partner @ TempoCap
FollowPierre Suhrcke on Facebook, Twitter or Linkedin.
[custom-twitter-feeds screenname=”pierresuhrcke”]
Spoiler title
Pierre’s extensive private equity background and experience in working with company management teams brings great value to the TempoCap portfolio. Pierre sector strengths are in financial services, fintech and insurtech, as well as data analytics and AI. Before joining TempoCap, Pierre served as the European General Partner of ABS ventures, a secondary buy-out of Deutsche Bank’s venture business (80 companies), and managed 3 vintages to a successful exit. Prior to this Pierre spent 17 years at Deutsche Bank London and Frankfurt notably as the Global Head of Risk Management and Managing Director of the Venture Business. Pierre Suhrcke has been on the board of over 20 successful companies in the US and Europe. Among them RiskMetrics, the global leader in Financial Risk Analytics, Trema the leading risk and treasury management company and Adeptra the global market leader in credit card fraud.
Learn more about Pierre Suhrcke on Crunchbase… Read more aboutTempoCap on Crunchbase…
Peter Charlton
Venture Partner @ Imperial Innovations
FollowPeter Charlton on Facebook, Twitter or Linkedin.
Spoiler title
Dr Peter (Pete) Charlton has a long history of working in biotech and pharma, and most recently ran the UK operations for Vertex Pharma. In that role he had line management of the Biology Division – responsible for Protein Biochemistry, Crystallography/Structural Biology, Cell Biology, Enzymology and Pharmacology Leadership and development of UK Research Portfolio from target identification through to nomination of clinical candidate. His focus was mainly oncology and neurodegenerative disease (previous areas have included sepsis and Multiple Sclerosis). Prior to Vertex Pete was at Xenova Group plc for 13 years, latterly as the Head of Biology. Prior to that he was a Senior Research Leader at GlaxoSmithKline for 8 years. Pete Charlton has a DPhil in Chemistry and Enzymology from the University of Sussex.
Learn more about Peter Charlton on Crunchbase…Imperial Innovations is a technology commercialization and venture capital investor that focuses on technology. Read more aboutImperial Innovations on Crunchbase…
Dyson Bogg
Venture Partner @ GMG Ventures
FollowDyson Bogg on Facebook, Twitter or Linkedin.
GMG Ventures is an early stage venture capital fund that invests in companies related to media-tech. Read more aboutGMG Ventures on Crunchbase…
Arek Wylegalski
Venture Partner @ Firstminute Capital
FollowArek Wylegalski on Facebook, Twitter or Linkedin.
Spoiler title
Arek is a Venture Partner at firstminute capital focusing on Blockchain and FinTech. Prior he was a Partner at an AI-focused seed fund, Fly Ventures, and an investor at Index Ventures. He led or worked on investments into: Wayve, Pyka, Revolut, Bonify, Culture Amp, Dubsmash, Prodigy, Property Partner, Funding Circle and others. He joined Index after Avenue Capital, a $15Bn AUM hedge fund, where he focused on special situations. Arek started his career in investment banking, trading credit for Barclays Capital and then in M&A advisory. He speaks publicly, mostly about blockchain, and is an active contributor to the start-up scene in London. He has been a long-time mentor and an investment committee member at Seedcamp. Arek is currently launching a fund dedicated to opportunities in the blockchain space across both equity and crypto-assets.
Learn more about Arek Wylegalski on Crunchbase… Read more aboutFirstminute Capital on Crunchbase…
Cian Hughes
Venture Partner @ Sure Ventures
FollowCian Hughes on Facebook, Twitter or Linkedin.
Spoiler title
Cian Hughes is a Cambridge, UK based venture capitalist and technology entrepreneur with over 20 years operational experience in the areas of venture capital, accelerators, executive networks, software solutions, mobile platforms and supply chain operations. Previously Cian was an executive with Lotus Inc. (now IBM), Intel Corporation and Palm Inc. as well as being Vice President of Operations for the San Francisco and San Jose, California-based Silicon Valley Global (SVG) Partners. In addition to venture capital and software executive positions, he also ran a solar manufacturing facility in Cardiff Wales and global smartphone repair, service and reverse logistics centers in the Czech Republic and the UK. Cian holds a BSc in Mathematics and Physics from University College Dublin (UCD) and a post-graduate higher diploma in Business Management from Trinity College Dublin (TCD).
Learn more about Cian Hughes on Crunchbase… Read more aboutSure Ventures on Crunchbase…
Ameya Upadhyay
Venture Partner @ Flourish Ventures
FollowAmeya Upadhyay on Facebook, Twitter or Linkedin.
Read more aboutFlourish Ventures on Crunchbase…
Andrew Bayliffe
Venture Partner @ Apple Tree Partners
FollowAndrew Bayliffe on Facebook, Twitter or Linkedin.
Spoiler title
Andrew Bayliffe is a venture partner at ATP. With more than 20 years of leadership experience in the biopharmaceutical industry, he possesses expertise in the discovery and development of both small molecule and antibody therapeutics across a broad range of diseases areas. Most recently, at GlaxoSmithKline (GSK), he served as head of the Fibrosis and Lung Injury Discovery unit at GSK’s R&D headquarters in Stevenage, UK, and held senior roles in antibody discovery and development in the US and UK. Andrew is an honorary professor at the Wolfson Institute of Experimental Medicine at Queens College in Belfast. He completed his undergraduate and PhD studies in pharmacology, physiology, and molecular biology at Manchester University and Leeds University in the UK.
Learn more about Andrew Bayliffe on Crunchbase… Read more aboutApple Tree Partners on Crunchbase…
Denise Kelly
Venture Partner @ Seventure Partners
FollowDenise Kelly on Facebook, Twitter or Linkedin.
Spoiler title
Denise joined Seventure Partners in September 2015 as a Consultant in the Life Sciences team for the microbiome field. Denise is currently based in Aberdeen, Scotland. As specialist in research on the human microbiome, she is responsible for relationships within the scientific and academic communities on behalf of Seventure Partners, identifying new investment opportunities in the field specific to the microbiome. Prior to joining Seventure, Denise led her own research team at the University of Aberdeen at the world renowned Rowett Institute. Denise has acquired more than 20 years of experience in intestinal microbiology and immunology. She was Founding President, General Manager, and Sales Director of GT Biologics, one of the first translational research spinouts developing innovative therapies from the microbiome.Her research is the source of many European and American patent applications. During her career, Denise worked with pharmaceutical and healthcare companies on several translational research projects. Denise received a BSc and a PhD from Queen’s University in Belfast. She is Professor Emeritus of the University of Aberdeen.
Learn more about Denise Kelly on Crunchbase… Read more aboutSeventure Partners on Crunchbase…
Kevin Sara
Venture Partner @ Aster
FollowKevin Sara on Facebook, Twitter or Linkedin.
Spoiler title
Kevin has over 20 years experience as an investor and entrepreneur. He was responsible for technology principal investments at Nomura, and co-founded Hazel Capital, one of the first cleantech investment managers in London. He also founded Nur Energie, a solar development company with landmark projects in France, Italy, Greece and Tunisia. He has a degree in Physics from Vassar College and an MBA from the Ecole Nationale des Ponts et Chaussées, and previously worked as a management consultant and investment banker. With Aster, Kevin is developing a thematic fund focused on Sustainable Aviation. The fund will back entrepreneurs developing new electric aircraft and associated technologies.
Learn more about Kevin Sara on Crunchbase… Read more aboutAster on Crunchbase…
Cliff Hinrichs
Venture Partner @ Fuse Venture Partners
FollowCliff Hinrichs on Facebook, Twitter or Linkedin.
Read more aboutFuse Venture Partners on Crunchbase…
Simon Greenman
Advisor, formerly Venture Partner @ DN Capital
FollowSimon Greenman on Facebook, Twitter or Linkedin.
[custom-twitter-feeds screenname=”sgreenman”]
Spoiler title
Simon Greenman has over twenty years of leading digital transformations through technology, data science, and AI. He is co-founder and partner in Best Practice AI, a London based AI executive advisory with a leading library of AI use cases and case studies. Earlier in his career, Simon was a co-founder of MapQuest.com, one of the first internet brands. He has over ten years as a chief digital officer leading transformations of media companies for private equity. He has also consulted or worked for HomeAdvisor Europe, AOL, Bowers & Wilkins, and Accenture. Simon is highly active in the AI startup community. He is an AI entrepreneur in Resident at Seedcamp, co-president of the Harvard Business School Alumni Angels of London, and an advisor and former venture partner at DN Capital. He holds an MBA from the Harvard Business School and a BA in computing and artificial intelligence from the University of Sussex.
Learn more about Simon Greenman on Crunchbase… Read more aboutDN Capital on Crunchbase…
Elena Buchen
Venture Partner @ Polar Light Ventures
FollowElena Buchen on Facebook, Twitter or Linkedin.
Spoiler title
Elena is a Venture Partner at Polar Light Ventures AG, an investment firm based in Switzerland focusing on early-stage technology ventures. She previously served as an advisor to the Mara Foundation and the Varkey Gems Foundation where she was involved in the implementation of social-impact programmes in Kenya, Uganda and Nigeria. Before her philanthropy engagements, she worked for Roland Berger Strategy Consultants in Russia and Germany. Elena holds a Master of Business Administration and Economics from WHU – Otto Beisheim School of Management in Germany.
Learn more about Elena Buchen on Crunchbase… Read more aboutPolar Light Ventures on Crunchbase…
David Lofthouse
Venture Partner @ Clocktower Technology Ventures
FollowDavid Lofthouse on Facebook, Twitter or Linkedin.
Spoiler title
David is London-based Venture Partner, leading Clocktower Technology Ventures in the UK and Europe. He is responsible for all fintech investment activity, including originations, investment execution and portfolio management in this region. David was previously Co-Founder and CIO of Prologue Capital, a highly successful fixed income global macro hedge fund. David’s earlier career in trading spans JP Morgan, Greenwich Capital and Goldman Sachs. David holds a BSc in Chemical Engineering from the University of Nottingham. David lives in Mayfair with his wife and young child.
Learn more about David Lofthouse on Crunchbase… Read more aboutClocktower Technology Ventures on Crunchbase…
Tim Lebus
Venture Partner @ Octopus Ventures
FollowTim Lebus on Facebook, Twitter or Linkedin.
Spoiler title
Tim Lebus has spent over 30 years in private equity and banking. He is currently Senior Adviser to Duke Street, the mid-market private equity group, having previously been a Partner from 2001 to 2012. Prior to joining Duke Street, Tim worked for more than 20 years as an investment banker, most recently as a Managing Director in the Financial Sponsor group at Deutsche Bank. He also works with Octopus Ventures, the venture capital arm of Octopus Investments. He is as an observer to a number of Octopus Ventures investee companies and is a director of Octopus Titan VCT 3 plc. In addition, he is a director of Bibby Line Group Limited. Tim qualified a lawyer and practised as a barrister in London and subsequently as a corporate lawyer in New York. He holds a degree in law from Cambridge University.
Learn more about Tim Lebus on Crunchbase… Read more aboutOctopus Ventures on Crunchbase…
Jim Faulkner
Venture Partner @ Apple Tree Partners
FollowJim Faulkner on Facebook, Twitter or Linkedin.
Spoiler title
Jim Faulkner is a venture partner at ATP. A highly experienced biopharmaceutical development leader with specialist skills in gene and cell therapy, he has been significantly involved in taking more than 25 different medicines into the clinic, including multiple CAR-T assets. Most recently, Jim headed Product Delivery for Autolus Ltd, a clinical-stage CAR-T company spun out of University College London. During his tenure, he set up and led a team of over 75 scientists and engineers in the US and UK responsible for process development, technical operations, engineering and supply chain, and he served on the leadership team that took Autolus from start-up to successful IPO in three years. Prior to that, Jim held various leadership roles at GlaxoSmithKline, including overseeing the chemistry, manufacturing and controls (CMC) development and supply of a portfolio of pioneering product types that included gene and cell therapies, oligonucleotides, therapeutic enzymes, and molecular chaperones, and playing a significant role in the successful filing of the first-ever autologous ex vivo gene/cell therapy product license (for Strimvelis™). He started his career at British Biotech, the first biotechnology company to be publicly listed in the UK. Jim earned a BSc in biotechnology from the University of Leeds and completed his PhD in molecular biology at the Centre for Applied Microbiology and Research.
Learn more about Jim Faulkner on Crunchbase… Read more aboutApple Tree Partners on Crunchbase…
Peter Horsburgh
Venture Partner and Founder @ ETF Partners
FollowPeter Horsburgh on Facebook, Twitter or Linkedin.
ETF Partners supports talented entrepreneurs and management teams with investment capital and experience. Read more aboutETF Partners on Crunchbase…
Alan Duncan
Venture Partner @ Molten Ventures
FollowAlan Duncan on Facebook, Twitter or Linkedin.
Spoiler title
Alan has been in the venture capital industry for more than twenty years, initially through establishing a corporate venturing fund for Ferranti and then with Foreign & Colonial Ventures, Newmarket Venture Capital and Prelude Ventures. He joined DFJ Esprit when it was formed in 2006. Alan is responsible for a portfolio of DFJ Esprit’s electronics investments including Phyworks, Lime Microsystems, SiConnect, XMOS and DisplayLink. His previous investments have included Alphamosaic (sold to Broadcom) and nCipher (IPO on LSE). Alan has an electronic engineering background and gained his industrial experience in computer systems with Ferranti plc. Alan is a past member of the European Venture Capital Association High Tech Committee and lecturer on the EVCA’s venture capital professional training courses.
Learn more about Alan Duncan on Crunchbase…Molten Ventures is Europe’s largest listed tech VC firm. We inject the most visionary companies with energy to help them transform and grow. Read more aboutMolten Ventures on Crunchbase…
Iain Wilcock
Venture Partner @ Seventure Partners
FollowIain Wilcock on Facebook, Twitter or Linkedin.
Spoiler title
Iain established and ran the healthcare investment business of Quester Capital, an early-stage venture capital business, for over 10 years. n 2000, Iain founded Vela Venture Partners to advise early-stage investors in the UK. He is now working at NESTA as an Investment Director; and at Seventure, a French venture capital company, as its UK healthcare investment advisor. He is an experienced non-executive director, having served on the boards of biotechnology and med-tech companies, including Vivacta, Avidex, Oxxon, Lectus, and Xention. He is a member of the British Venture Capital Association, the BioIndustry Association and UNICO. Iain was recently appointed to the Strategic Advisory Board for IP Policy to advise the UK-IPO (UK Intellectual Property Office).
Learn more about Iain Wilcock on Crunchbase… Read more aboutSeventure Partners on Crunchbase…
Andrew Witty
Venture Partner @ Hatteras Venture Partners
FollowAndrew Witty on Facebook, Twitter or Linkedin.
Spoiler title
Andrew became Chief Executive Officer of GlaxoSmithKline plc on 21 May 2008. He is a member of the Board and Corporate Executive Team. Andrew joined Glaxo in 1985 and has held a variety of Sales and Marketing roles in the UK and abroad including working in the Company’s International New Products groups, both in the Respiratory and HIV/Infectious disease fields. Outside of the UK Andrew has worked in South Africa, the USA and Singapore where he led the Group’s operations as Senior Vice President, Asia Pacific. While in Singapore Andrew was a Board Member of the Singapore Economic Development Board and the Singapore Land Authority. In 2003 he was awarded the Public Service Medal by the Government of Singapore and in August 2012 was also awarded the Public Service Star. In 2003 Andrew was appointed President of GSK Europe and joined GSK’s Corporate Executive Team. Andrew has served in numerous advisory roles to Governments around the world including South Africa, Singapore, Guangzhou China and the UK, where he was a member of the Prime Minister’s Business Advisory Group from 2010 – 2015. He was awarded a Knighthood for services to the economy and to the UK pharmaceutical industry in the 2012 New Year Honours List. In 2014, Andrew was appointed to be a Business Ambassador for the UK Government and in 2015, Andrew became a member of the China-Britain Business Council Advisory Council. Andrew is Chancellor of the University of Nottingham, a position he took up on 1 January 2013. Andrew has a Joint Honours BA in Economics from the University of Nottingham.
Learn more about Andrew Witty on Crunchbase… Read more aboutHatteras Venture Partners on Crunchbase…
Patrick Round
Venture Partner @ Forbion Capital Partners
FollowPatrick Round on Facebook, Twitter or Linkedin.
Spoiler title
Before joining NorthSea Therapeutics, Patrick Round was CMO and CEO of Xention Limited which conducted all the development work for Dezima BV which was acquired by Amgen. Before Xention he was Senior Vice President of Development at Cambridge Antibody Technology when it was acquired by Astra Zeneca. He also served as Director of Development at Celltech, Director of Clinical Development at Glaxo Wellcome and started his pharma career as a medical adviser at Novo Nordisk in 1991 in the UK and later in Denmark. He has also worked as CMO for a number of Biotech start-up companies. He received his medical degree from Charing Cross Hospital Medical School in London in 1982, became a Fellow of the Royal College of Anaesthetists in 1990 and a Fellow of the Faculty of Pharmaceutical Medicine in 2005
Learn more about Patrick Round on Crunchbase… Read more aboutForbion Capital Partners on Crunchbase…
Marvin Ma
Venture Partner @ Octopus Ventures
FollowMarvin Ma on Facebook, Twitter or Linkedin.
Spoiler title
Marvin Ma joined as Octopus Venture Partner in March 2016. He is actively helping Octopus as well as its portfolios on China strategy and relationship building. Marvin is also Founder of Longhill Investments, an alternative investment firm based in Shanghai, helping Chinese institutions and family office for outbound investments and deal makings. Before that Marvin was a venture investor in HSBC Strategic Innovation Investment team covering Fintech Investments and ex Investment Banker in Torch Partners, a tech focus corporate finance advisory firm.
Learn more about Marvin Ma on Crunchbase… Read more aboutOctopus Ventures on Crunchbase…
Anthony Collinson
Venture Partner @ Octopus Ventures
FollowAnthony Collinson on Facebook, Twitter or Linkedin.
Spoiler title
Anthony was a co-founder of Katalyst Ventures, which was launched in 2000. As Chairman of the company he helped build its private angel network to over 100 people, as well as raising over £18 million to fund a portfolio of 25 companies before Katalyst Ventures was sold to Octopus in 2007. Now a consultant, he acts as a director and observer to a number of investee companies within the team’s portfolio. He has a manufacturing, operational and general management background as well as extensive small business experience. He was a director of Porvair PLC and Managing Director of Porvair International Ltd. Previously Anthony was managing director of Scotfresh Limited, Irish Leathers Group Plc and Holmes Hall Tanners Limited.
Learn more about Anthony Collinson on Crunchbase… Read more aboutOctopus Ventures on Crunchbase…
Shikha Goyal
Venture Partner @ Imaginable Futures
FollowShikha Goyal on Facebook, Twitter or Linkedin.
Spoiler title
Shikha Goyal is a Venture Partner at Imaginable Futures. Prior to joining Imaginable Futures and Omidyar Network, she worked at the Children’s Investment Fund Foundation (CIFF) where she led investment and management of programs to improve basic literacy and numeracy for children in India and Sub-Saharan Africa. She was responsible for a portfolio of over $60 million including CIFF’s investment in Early Learning Partnership (a multi-donor trust fund with the World Bank), Educate Girls India (the world’s first education development impact bond), and Tayari (a low cost, early childhood education model across 1,500 schools in Kenya). Before CIFF, Shikha was at Accenture advising European utilities on strategic due-diligence, operational improvement, and regulatory strategy. She started her career as an R&D engineer in an energy meter manufacturing start-up in India. Shikha is a board member for Innovation Edge, an observer for SPARK Schools and SmartStart, and sits on the steering committee for Global Schools Forum.
Learn more about Shikha Goyal on Crunchbase… Read more aboutImaginable Futures on Crunchbase…
Alison Fielding
Venture Partner @ IP Group Plc
FollowAlison Fielding on Facebook, Twitter or Linkedin.
Spoiler title
Ali co-founded Techtran Group Ltd and was the Chief Operating Officer of Techtran when it was acquired by IP Group in January 2005. She was a director of IP Group until July 2013 when she moved into a new role with the Company as Director of IP Impact. Previously, Ali spent five years at McKinsey & Co where she consulted primarily to the pharmaceutical and health care sectors. Prior to McKinsey, Ali spent four years as a development chemist for Zeneca, performing technical roles in the speciality chemicals and agrochemicals divisions. Ali holds an MBA from Manchester Business School, a Ph.D. in Organic Chemistry and a first class degree in Chemistry from the University of Glasgow. Ali is a trustee of Care International UK, one of the world’s three biggest aid agencies working with 82m people in 87 countries.
Learn more about Alison Fielding on Crunchbase…IP Group is an IP commercialization company specializing in evolving great ideas into world-changing businesses. Read more aboutIP Group Plc on Crunchbase…
Steve Crossan
Venture Partner @ Firstminute Capital
FollowSteve Crossan on Facebook, Twitter or Linkedin.
[custom-twitter-feeds screenname=”stevecrossan”]
Spoiler title
Steve is an Executive-in-Residence (XiR) at Atomico, focused on helping their portfolio company founders with their Product and Go-To-Market strategies. He also works closely with the Engineering team building a platform that allows Atomico to be efficient in discovering and being responsive to great companies & founders and oversees other tech solutions to support the firm’s core business. Prior to joining Atomico he worked at the world’s leading AI research company, DeepMind, in London. At Deepmind, Steve led the Product team responsible for putting DeepMind’s technology into Google – from data centre optimization to Google Assistant and protein folding – and reported directly into Deepmind co-founder Mustafa Suleyman. He joined DeepMind after several years at Google working on the Google Maps, Gmail, and Google Search product teams. In 2011, during the Arab Spring, he launched speak2tweet to open access to social media when the internet was cut off in several countries. Before all this he left a Ph.D. in AI at Sussex unfinished to start a series of startups including Runtime Collective which later became brandwatch.com. He also serves as a Venture Partner at seed investor firstminute capital.
Learn more about Steve Crossan on Crunchbase… Read more aboutFirstminute Capital on Crunchbase…
Ian Perry
Venture Partner @ Octopus Ventures
FollowIan Perry on Facebook, Twitter or Linkedin.
Spoiler title
Ian combines over 25 years sales, operations and general management experience in the IT industry with domain experience in the communications industry spanning wireline, wireless and IP service provider markets. Following consistent success in sales and sales management positions at Information Technology Ltd, Ingres and Sybase, Ian went on to join Portal Software as Vice President, EMEA in 1998. Building the EMEA organization from scratch his four year tenure at Portal Software saw the company rapidly achieve a dominant market position in convergent billing and customer care solutions securing the majority of Tier 1 operators across EMEA, and supported a highly successful NASDAQ IPO. Since leaving Portal in 2002, Ian operates an independent consulting business active in supporting and investing in early stage organizations spanning SaaS, direct / enterprise, channel and consumer business models. Ian currently holds non-executive board positions at Cloudmark Inc, Eseye Ltd, Central Europe On-Demand Zrt and Ontology Ltd.
Learn more about Ian Perry on Crunchbase… Read more aboutOctopus Ventures on Crunchbase…
Matthew Mead
Venture Partner @ Mercia Asset Management PLC
FollowMatthew Mead on Facebook, Twitter or Linkedin.
[custom-twitter-feeds screenname=”mattmead24″]
Spoiler title
Matt is the Chief Investment Officer of Mercia Technologies PLC and joined the business in May 2015. He has over 20 years’ experience in early-stage technology investment. Matt oversees all of the investment activity of the Group across venture, growth equity and debt, in addition to managing the Investment Team. He also sits on the boards of portfolio companies Impression Technology, Science Warehouse and Intelligent Positioning. Matt has been a Board director of both UK and US software companies, including Metatstorm, Datanomic, Insensys and Vistorm, which have all successfully exited. He worked at 3i from 1995 to 2009 where latterly he managed the disposal of its venture portfolio, realising over £200.0million of proceeds through sales, and managed its pan-European venture portfolio team, returning over £180.0million of cash in two years. Matt subsequently joined the innovation agency, NESTA, as managing director of investments, to run its £30.0million venture capital fund and in 2010 was appointed CIO, managing all investment activity including its £350.0million trust assets and its venture portfolio.
Learn more about Matthew Mead on Crunchbase…Mercia is a proactive, specialist asset manager focused on supporting regional businesses to achieve their growth aspirations. Read more aboutMercia Asset Management PLC on Crunchbase…
Stephen Bullock
Venture Partner @ Beacon Capital
FollowStephen Bullock on Facebook, Twitter or Linkedin.
Read more aboutBeacon Capital on Crunchbase…
Larry Levine
Venture Partner @ Beacon Capital
FollowLarry Levine on Facebook, Twitter or Linkedin.
Read more aboutBeacon Capital on Crunchbase…
Adrian Colyer
Venture Partner @ Accel
FollowAdrian Colyer on Facebook, Twitter or Linkedin.
[custom-twitter-feeds screenname=”adriancolyer”]
Read more aboutAccel on Crunchbase…
Philip Gasslander
Venture Partner @ Pioneer Fund
FollowPhilip Gasslander on Facebook, Twitter or Linkedin.
[custom-twitter-feeds screenname=”philgasslander”]
Read more aboutPioneer Fund on Crunchbase…
Chris Spencer
Venture Partner @ Catapult Ventures
FollowChris Spencer on Facebook, Twitter or Linkedin.
Spoiler title
Chris is a Venture Partner with Catapult’s GM&C Life Sciences Fund, where he assesses investment opportunities and works with the Fund’s smaller investments to help companies successfully grow, with a particular focus on digital health technologies. Chris was until recently CEO of EMIS Group plc (FTSE listed), the UK leader in healthcare software and solutions across nearly every major healthcare setting – from GP surgeries to high street pharmacies, and hospitals to community services. Chris joined EMIS in 1999 and his roles have included Commercial Development Director, Group Legal Counsel, Chief Administrative Officer and since 2013, CEO. Chris has nearly 40 years’ experience of general management, leadership, law and software/digital development within the healthcare, legal and educational sectors both as a founder of his own companies and a senior manager in established companies. Chris graduated from Leeds University with a LLB in Law.
Learn more about Chris Spencer on Crunchbase…Catapult Ventures specialises in providing Equity Capital for businesses requiring between £50k and £2m. Read more aboutCatapult Ventures on Crunchbase…
Dionysia Kaplan
Venture Partner @ Beacon Capital
FollowDionysia Kaplan on Facebook, Twitter or Linkedin.
Read more aboutBeacon Capital on Crunchbase…
David Ryan
Venture Partner @ Beacon Capital
FollowDavid Ryan on Facebook, Twitter or Linkedin.
Read more aboutBeacon Capital on Crunchbase…
Greg Kelton
Venture Partner @ Rubicon Venture Capital
FollowGreg Kelton on Facebook, Twitter or Linkedin.
Read more aboutRubicon Venture Capital on Crunchbase…
Steve Collins
Venture Partner @ Frontline Ventures
FollowSteve Collins on Facebook, Twitter or Linkedin.
Read more aboutFrontline Ventures on Crunchbase…
Lara Morgan
Venture Partner @ Scentered
FollowLara Morgan on Facebook, Twitter or Linkedin.
[custom-twitter-feeds screenname=”IamLaraMorgan”]
Scentered is an online shop that offers beauty, health, wellness and aromatherapy products. Read more aboutScentered on Crunchbase…
Rupesh Chatwani
Venture Partner @ RLC Ventures
FollowRupesh Chatwani on Facebook, Twitter or Linkedin.
[custom-twitter-feeds screenname=”rupechat”]
RLC Ventures is an award-winning VC which continues to back founders building global tech companies, from idea to exit. Read more aboutRLC Ventures on Crunchbase…
Michael Carter
Venture Partner @ SV Health Investors
FollowMichael Carter on Facebook, Twitter or Linkedin.
Spoiler title
Dr. Michael Carter joined SVLS in 1998 as a Venture Partner. From 1986 to 1998 Michael was on the board of ICI/Zeneca Pharmaceuticals and from 1995 – 1998 was also a board member of Salick Healthcare – a US subsidiary of Zeneca. He was International Marketing Director at ICI/Zeneca Pharmaceuticals; in addition as International Medical Director he was involved in the clinical and commercial development of over 20 new medicines. For 10 years (1986 – 1996) he was a member of the UK Government’s Medicines Commission. He has also worked at Roche Products as Director of the Pharmaceutical Division. Before entering the pharmaceutical industry, Michael practiced as a physician for eleven years. Michael is currently on the boards of GTx Inc, Oxagen / Atopix, Oncoethix, Santarus Inc. and a member of the Strategic Advisory Board of Healthcare Royalty Partners. Previously Dr Carter was on the boards of CancerVax, Genosis, Fulcrum, KuDOS, Micromet and Warner Chilcott.
Learn more about Michael Carter on Crunchbase… Read more aboutSV Health Investors on Crunchbase…
Hamish Cameron
Venture Partner @ SV Health Investors
FollowHamish Cameron on Facebook, Twitter or Linkedin.
Read more aboutSV Health Investors on Crunchbase…
David Whitcombe
Venture Partner @ GM&C Life Sciences Fund
FollowDavid Whitcombe on Facebook, Twitter or Linkedin.
Spoiler title
David is a Venture Partner with Catapult’s GM&C Life Sciences Fund, where he assesses investment opportunities and works with the Fund’s smaller investments to help companies successfully grow. David is a well-known consultant and non-executive director/Chairman who co-founded DxS Diagnostics in 2000 to exploit a personalised medicine technology he had invented while with AstraZeneca Diagnostics. DxS was sold to Qiagen in September 2009 for in excess of £100m. Prior to DxS, David was Head of Technology Development at AstraZenica Diagnostics for four years where he led a team of up to 15 scientists working on new genome technologies. David began his career as a Post-Doctoral Fellow with Warwick University Department of Biological Sciences, before joining Cambridge University Department of Medicine as a Senior Post-Doctoral Fellow where he researched the Genetics of Human Disease for six years. David holds a First Class BSc in Genetics from the University of York and PhD in Biochemistry/Molecular Biology from the University of Leicester.
Learn more about David Whitcombe on Crunchbase… Read more aboutGM&C Life Sciences Fund on Crunchbase…
Alan Cairns
Venture Partner @ Octopus Ventures
FollowAlan Cairns on Facebook, Twitter or Linkedin.
[custom-twitter-feeds screenname=”alancairns1″]
Spoiler title
Alan, who joined Octopus Ventures in 2018, is a Venture Partner focussing on People & Talent Strategies across the portfolio. He’s a seasoned digital/tech focussed chief people officer having spent 8 years helping take MoneySupermarket from IPO, through a range of acquisitions including the substantive Moneysavingexpert, to a FTSE 150 with a £2Billion Enterprise value. He hired the executive team including CEO, several NED’s and the leadership team as well as building out the people strategy. He’s spent the past two years as CPO of MOO where he made some significant exec hires, codefied it’s culture and values as well as launching an all employee stock option plan. Alan is currently CPO for a systematic hedge fund, a proud mentor for ALT and an advisor to a nascent startup in psychometrics.
Learn more about Alan Cairns on Crunchbase… Read more aboutOctopus Ventures on Crunchbase…
David Parker
Venture Partner @ Imperial Innovations
FollowDavid Parker on Facebook, Twitter or Linkedin.
Spoiler title
David joined Imperial Innovations in 2014 as a Venture Partner in the Technology Ventures Team. He has extensive experience in building companies from early stage through to private and public exits, along with a long career in senior management in technology corporates. Notable companies include HP, Agilent Technologies, Marconi, SPI and TRUMPF. He is currently a board member at several technology companies including Perpetuum where he serves as the Chairman, and OPS Innovations. David holds a PhD from Imperial College, is a Fellow of the Institute of Physics and was recently elected a Fellow of the Royal Academy of Engineering.
Learn more about David Parker on Crunchbase…Imperial Innovations is a technology commercialization and venture capital investor that focuses on technology. Read more aboutImperial Innovations on Crunchbase…
David Whitcombe
Venture Partner @ Catapult Ventures
FollowDavid Whitcombe on Facebook, Twitter or Linkedin.
Spoiler title
David is a Venture Partner with Catapult’s GM&C Life Sciences Fund, where he assesses investment opportunities and works with the Fund’s smaller investments to help companies successfully grow. David is a well-known consultant and non-executive director/Chairman who co-founded DxS Diagnostics in 2000 to exploit a personalised medicine technology he had invented while with AstraZeneca Diagnostics. DxS was sold to Qiagen in September 2009 for in excess of £100m. Prior to DxS, David was Head of Technology Development at AstraZenica Diagnostics for four years where he led a team of up to 15 scientists working on new genome technologies. David began his career as a Post-Doctoral Fellow with Warwick University Department of Biological Sciences, before joining Cambridge University Department of Medicine as a Senior Post-Doctoral Fellow where he researched the Genetics of Human Disease for six years. David holds a First Class BSc in Genetics from the University of York and PhD in Biochemistry/Molecular Biology from the University of Leicester.
Learn more about David Whitcombe on Crunchbase…Catapult Ventures specialises in providing Equity Capital for businesses requiring between £50k and £2m. Read more aboutCatapult Ventures on Crunchbase…
David Whitcombe
Venture Partner @ Catapult Ventures
FollowDavid Whitcombe on Facebook, Twitter or Linkedin.
Spoiler title
David is a Venture Partner with Catapult’s GM&C Life Sciences Fund, where he assesses investment opportunities and works with the Fund’s smaller investments to help companies successfully grow. David is a well-known consultant and non-executive director/Chairman who co-founded DxS Diagnostics in 2000 to exploit a personalised medicine technology he had invented while with AstraZeneca Diagnostics. DxS was sold to Qiagen in September 2009 for in excess of £100m. Prior to DxS, David was Head of Technology Development at AstraZenica Diagnostics for four years where he led a team of up to 15 scientists working on new genome technologies. David began his career as a Post-Doctoral Fellow with Warwick University Department of Biological Sciences, before joining Cambridge University Department of Medicine as a Senior Post-Doctoral Fellow where he researched the Genetics of Human Disease for six years. David holds a First Class BSc in Genetics from the University of York and PhD in Biochemistry/Molecular Biology from the University of Leicester.
Learn more about David Whitcombe on Crunchbase…Catapult Ventures specialises in providing Equity Capital for businesses requiring between £50k and £2m. Read more aboutCatapult Ventures on Crunchbase…
Tony Flinn
Venture Partner @ GM&C Life Sciences Fund
FollowTony Flinn on Facebook, Twitter or Linkedin.
Spoiler title
Tony is a Venture Partner with Catapult’s GM&C Life Sciences Fund, where he helps assess service company (CRO) investment opportunities and works with the Fund’s smaller investments to help companies successfully grow. Tony is a well-known non-executive director and motivational speaker who co-founded Onyx Scientific in 2000 to offer contract chemistry services to many of the world’s leading drug developers. He grew the business to become one the fastest growing technology companies in the UK, employing more than 60 staff at its peak, managed an MBO in 2007, and ultimately sold the business to IPCA, a large Indian pharmaceutical service provider, in 2011. Tony began his career as a Post-Doctoral Research Fellow, first with the Cancer Research Institute, and then with Oxford University. After a period as a Research Chemist with Dow Chemical he began the first of several business development roles.
Learn more about Tony Flinn on Crunchbase… Read more aboutGM&C Life Sciences Fund on Crunchbase…
Tony Flinn
Venture Partner @ GM&C Life Sciences Fund
FollowTony Flinn on Facebook, Twitter or Linkedin.
Spoiler title
Tony is a Venture Partner with Catapult’s GM&C Life Sciences Fund, where he helps assess service company (CRO) investment opportunities and works with the Fund’s smaller investments to help companies successfully grow. Tony is a well-known non-executive director and motivational speaker who co-founded Onyx Scientific in 2000 to offer contract chemistry services to many of the world’s leading drug developers. He grew the business to become one the fastest growing technology companies in the UK, employing more than 60 staff at its peak, managed an MBO in 2007, and ultimately sold the business to IPCA, a large Indian pharmaceutical service provider, in 2011. Tony began his career as a Post-Doctoral Research Fellow, first with the Cancer Research Institute, and then with Oxford University. After a period as a Research Chemist with Dow Chemical he began the first of several business development roles.
Learn more about Tony Flinn on Crunchbase… Read more aboutGM&C Life Sciences Fund on Crunchbase…
Philip Lay
Venture Partner @ Octopus Ventures
FollowPhilip Lay on Facebook, Twitter or Linkedin.
[custom-twitter-feeds screenname=”philipflay”]
Spoiler title
Philip has been a partner at the Chasm Group, a Silicon Valley based strategy consulting firm founded by Geoffrey Moore, for the past 24 years. He joined Octopus Ventures as a Venture Partner in January 2018, after moving from San Francisco back to the UK. Earlier Philip had a successful entrepreneurial career, co-founding and leading a successful security and communications software company, TGR Software, before it was acquired, and before that he was a sales executive at IBM in the UK. Philip focuses mainly on B2B software/Saas. He has advised dozens of companies ranging from major tech companies such as Autodesk, HP, NetApp, Netsuite, SAP, Rackspace and Salesforce.com, to mid-sized players and startups entering their scale-up growth phase. Among the key themes of his work are: playing for power, land & expand business strategy and enterprise customer engagement. Philip has also delivered keynotes and moderated panels at industry and company conferences around the world; he teaches full-time MBA students at IESE in Barcelona
Learn more about Philip Lay on Crunchbase… Read more aboutOctopus Ventures on Crunchbase…
Philip Lay
Venture Partner @ Octopus Ventures
FollowPhilip Lay on Facebook, Twitter or Linkedin.
[custom-twitter-feeds screenname=”philipflay”]
Spoiler title
Philip has been a partner at the Chasm Group, a Silicon Valley based strategy consulting firm founded by Geoffrey Moore, for the past 24 years. He joined Octopus Ventures as a Venture Partner in January 2018, after moving from San Francisco back to the UK. Earlier Philip had a successful entrepreneurial career, co-founding and leading a successful security and communications software company, TGR Software, before it was acquired, and before that he was a sales executive at IBM in the UK. Philip focuses mainly on B2B software/Saas. He has advised dozens of companies ranging from major tech companies such as Autodesk, HP, NetApp, Netsuite, SAP, Rackspace and Salesforce.com, to mid-sized players and startups entering their scale-up growth phase. Among the key themes of his work are: playing for power, land & expand business strategy and enterprise customer engagement. Philip has also delivered keynotes and moderated panels at industry and company conferences around the world; he teaches full-time MBA students at IESE in Barcelona
Learn more about Philip Lay on Crunchbase… Read more aboutOctopus Ventures on Crunchbase…
Ravinder Dhaliwal
Investor and Venture Partner @ Crane Venture Partners
FollowRavinder Dhaliwal on Facebook, Twitter or Linkedin.
[custom-twitter-feeds screenname=”ravsterd”]
Read more aboutCrane Venture Partners on Crunchbase…
Ravinder Dhaliwal
Investor and Venture Partner @ Crane Venture Partners
FollowRavinder Dhaliwal on Facebook, Twitter or Linkedin.
[custom-twitter-feeds screenname=”ravsterd”]
Read more aboutCrane Venture Partners on Crunchbase…
Lisa Rodwell
Venture Partner @ MMC Ventures
FollowLisa Rodwell on Facebook, Twitter or Linkedin.
[custom-twitter-feeds screenname=”rodwellian”]
Spoiler title
Lisa joined Nutmeg in 2018 bringing over 25 years’ experience growing some of the world’s most exciting businesses and brands, working exclusively in tech-enabled, online or app-based companies since 2002. At Nutmeg, she oversees the Customer Team, with responsibility for marketing and communications, strategic partnerships, personalised financial advice and the specialist customer support team. Prior to joining Nutmeg, Lisa has worked for some of the world’s largest and most recognisable brands, including: Procter & Gamble, Ogilvy, eBay, Yahoo!, and more recently MOO.COM, Wool and the Gang and Starling Bank. Having attained a Bachelor of Commerce Honours from Queen’s University in Canada, she has lived and worked in Canada, Sweden, Czech Republic and the UK.
Learn more about Lisa Rodwell on Crunchbase… Read more aboutMMC Ventures on Crunchbase…
Roberto Solari
Venture Partner @ Imperial Innovations
FollowRoberto Solari on Facebook, Twitter or Linkedin.
Spoiler title
Roberto is a Venture Partner at Imperial Innovations and his career has been focused at the interface of innovation and entrepreneurship, including technology transfer, venture capital, pharma, biotech and academia. He is currently working at the National Heart and Lung Institute, Imperial College London, on the mechanisms of Rhinovirus replication. He is an advisor to Imperial Innovations and Brandon Capital, and is on the board of Heptares and the Science Advisory Board of Astex Pharmaceuticals. Roberto was previously Vice President in GSK’s Respiratory Therapy Area based in Stevenage, UK where his role covered drug discovery from target identification through to proof of concept studies in man. Before joining GSK, Roberto was CEO of the UK Medical Research Council’s technology transfer arm, MRCT, creating spin out companies and developing an internal drug discovery group. He has advised and worked in venture capital firms Apax Partners and Abingworth following a period at GlaxoWellcome, and academic positions at the Institut de Biochimie, Universite de Lausanne and Liverpool University. He has a PhD in Physiology and Cell Biology from Nottingham University.
Learn more about Roberto Solari on Crunchbase…Imperial Innovations is a technology commercialization and venture capital investor that focuses on technology. Read more aboutImperial Innovations on Crunchbase…
Matthew Knowles
Venture Partner @ TempoCap
FollowMatthew Knowles on Facebook, Twitter or Linkedin.
Spoiler title
Matt joined TempoCap in 2017 following 19 years running HiFX, a global leader in digital international payments. He co-founded the business in 1998 and built the business up to be one of the largest non-bank players globally. In his time as CEO, Matt led the business through an MBO, 3 separate acquisitions (including the acquisition of XE) and the ultimate sale of HiFX in 2014 for $250m to Euronet Inc (Nasdaq: EEFT). Matt’s move into the venture capital industry is driven by his passion to help build great businesses. Matt studied Accountancy and Law at Kingston University.
Learn more about Matthew Knowles on Crunchbase… Read more aboutTempoCap on Crunchbase…
Stephen Margolis
Venture partner @ Wekix VC
FollowStephen Margolis on Facebook, Twitter or Linkedin.
Read more aboutWekix VC on Crunchbase…
Post Views: 523
David Friedland
